# Clinical Trial to Evaluate Efficacy and Safety of ROVASRO 10mg Versus CRESTOR 10mg in Hypercholesterolemic Patients

> **NCT03949374** · PHASE4 · COMPLETED · sponsor: **Yonsei University** · enrollment: 126 (actual)

## Conditions studied

- Hypercholesterolemia
- Dyslipidemias

## Interventions

- **DRUG:** CRESTOR, reference formulation of rosuvastatin
- **DRUG:** ROVASRO, generic formulation of rosuvastatin

## Key facts

- **NCT ID:** NCT03949374
- **Lead sponsor:** Yonsei University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-10-23
- **Primary completion:** 2018-04-16
- **Final completion:** 2018-06-01
- **Target enrollment:** 126 (ACTUAL)
- **Last updated:** 2019-05-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03949374

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03949374, "Clinical Trial to Evaluate Efficacy and Safety of ROVASRO 10mg Versus CRESTOR 10mg in Hypercholesterolemic Patients". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT03949374. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*